Irini Karydas SURGEON Director, Breast Center

• Wide local excision with radical axillary lymph node clearance in breast cancer. National and Kapodistrian University of Athens.

• ASCO (American Society of Clinical Oncology).
• Hellenic Society of Breast Surgery and Breast International Group (BIG).
• Hellenic Society of Surgery.
• Athens Medical Society.
• Hellenic Society of Breast Cancer research.
• Contact person EORTC Breast Cooperative Group.
• Hellenic Society of Psychosocial Oncology.
• Hellenic Society of Preventive Medicine.
• Hellenic Society of Senology.
• Hellenic Society of Oncology
• International Society against Breast Cancer.
• International Association for Breast research.
• International Society of Senology.
• Editorial Board in Hellenic Society of Senology.

• Director of Breast Center “HYGEIA” Hospital since 2003.
• Breast Clinic “AGIOS SAVVAS” Hospital.
• Guy’s Hospital Breast Unit.

Clinical Interest:

• Breast surgery performed more than 20.000 breast operations and examined more than 300.000 women with breast disease (case load)

Research Interest:

• Study of new drug development in breast cancer.
• EORTC Breast Cooperative Group Clinical studies (participation).
• Clinical research regarding the value of breast concerning surgery.
• Participation in immunology and transmission electromicroscopic research protocols “AGIOS SAVVAS” Hospital.
• Participation in immunohistochemical and histopathologic research laboratory protocols “AGIOS SAVVAS” Hospital, “HYGEIA” Hospital.

• 2011 honorary award from the women’s organisation “DEMOKRATIKOS SYNAGERMOS (DISY)-Cyprus for social contribution.
• First prizes on research papers at conferences. 
• Distinguished award for long standing clinical contribution “AGIOS SAVVAS” Hospital.

• Co-editor in Current mastology2007. 
• Publication: Senology 1992 Excerpta Medica.

• Fine needle aspiration cytology in primary breast angiosarcoma: a case report. Acta Cytol.2010 Sep-Oct;54 (5 Suppl): 764-70.
• Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer. Ann NY Acad Sci.2006 Sep;1075:235-4.3
• Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer. Ann Oncol.2004 Jan;15(1):95-9.
• Treatment of operable breast cancer in the elderly: a randomized clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. Eur J Cancer. 2003 Feb;39(3):300-8.
• Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding. Anticancer Res.1998 Jan-Feb;18(1B):625-9.
• Monocyte disorders associated with T cell defects in patients with solid tumors. Anticancer Res. 1992 Mar-Apr;12(2):489-94.
• Adjuvant androgen treatment of operable breast cancer — a 20 year analysis. Eur J Surg Oncol. 1987 Apr;13(2):113-7.
• Comparison of HER2 detection methods between central and regional laboratories in Greece. Clin Breast Cancer.2007 Oct;7(10):784-90.
• Inherited cancer predisposition syndromes in Greece. Anticancer Res.2008 Mar-Apr; 28(2B):1341-7. Review.
• Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding. Anticancer Res. 1998 Jan-Feb;18(1B):625-9.